Breast lumps natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 2: Line 2:
{{Breast lumps}}
{{Breast lumps}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{S.M}}


==Overview==
==Overview==

Revision as of 15:59, 18 December 2018

Breast lumps Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Breast lumps from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Breast lumps natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Breast lumps natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Breast lumps natural history, complications and prognosis

on Breast lumps natural history, complications and prognosis

Breast lumps natural history, complications and prognosis in the news

Blogs on Breast lumps natural history, complications and prognosis

Directions to Hospitals Treating Breast lumps

Risk calculators and risk factors for Breast lumps natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

If benign breast lumps left untreated, those proved to be benign both by clinical examination and cytological diagnosis, do not become malignant and 68% of benign breast lumps resolve by time mostly after 2 years [1].

Benign breast lumps should approved to be benign both clinically and cytologicaly. Because some of breast lumps which thought to be benign ones can turn to be malignant by cytological results [1]

breast lumps which approved to be benign both clinically and cytologicaly in women under 35 years can resolve over time if do not excised [1]

Natural History, Complications, and Prognosis

Natural History

  • Natural history of breast lumps did not well-studied and little is known about it [1]
  • Regarding to prevent missed malignancy and patient's reassurance, benign breast lumps are excised
  • The symptoms of benign breast lumps,especially fibroadenomas, usually develop in the second and third decade of life, and discrete breast lumps considered to be benign by clinical examination
  • If left untreated, 68% of patients with benign breast lumps may regress over 2 years
  • The histological reason for resolution of breast lumps is associated with the fact that lumps merge into stroma and hyalinization [2]

Complications

  • Common complications of breast lumps include
    • May develop into malignant lesion[1]
      • Assessment of malignancy risk in fibroadenomas is low[3]
      • No adenocarcinoma reported in fibroadenoma, only lobular neoplasia was seen in fibroaadenomas [4]

Prognosis

The relative risk (RR)of following breast cancer in different types of breast lumps[5][6][7]

  • Non-proliferative breast lesions have RR 1.2-1.4
  • Proliferative diseases (PD) have RR 1.7-2.1
  • Proliferative diseases (PD)with atypia hve RR more than 4 for breast cancer
  • PD and PD with atypia may be considered as early stages of breast cancers
  • Development risk to breast cancer from benign breast disease associated with 20 years follow-up

References

  1. 1.0 1.1 1.2 1.3 1.4 Sainsbury JR, Nicholson S, Needham GK, Wadehra V, Farndon JR (1988). "Natural history of the benign breast lump". Br J Surg. 75 (11): 1080–2. PMID 3208039.
  2. Kern WH, Clark RW (1973). "Retrogression of fibroadenomas of the breast". Am J Surg. 126 (1): 59–62. PMID 4123521.
  3. Pick PW, Iossifides IA (1984). "Occurrence of breast carcinoma within a fibroadenoma. A review". Arch Pathol Lab Med. 108 (7): 590–4. PMID 6329129.
  4. Haagensen, C. D. Diseases of the breast. Philadelphia: Saunders, 1971. Print.
  5. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K; et al. (2005). "Benign breast disease and the risk of breast cancer". N Engl J Med. 353 (3): 229–37. doi:10.1056/NEJMoa044383. PMID 16034008.
  6. Page DL, Dupont WD, Rogers LW, Rados MS (1985). "Atypical hyperplastic lesions of the female breast. A long-term follow-up study". Cancer. 55 (11): 2698–708. PMID 2986821.
  7. Neal L, Sandhu NP, Hieken TJ, Glazebrook KN, Mac Bride MB, Dilaveri CA; et al. (2014). "Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy". Mayo Clin Proc. 89 (4): 536–47. doi:10.1016/j.mayocp.2014.02.004. PMID 24684875.

Template:WH Template:WS